ALT-766

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameALT-766
Drug Alias NamePTB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation end product inhibitors
TargetsAdvanced glycation end product
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynvista Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynvista Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A